Download PDF
Synlett 2009(7): 1172-1174  
DOI: 10.1055/s-0028-1088149
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

A General and Efficient Synthesis of 2-Substituted Oxazolopyridines

Dan Xua, Xianfang Xub, Zongliang Liua, Li-Ping Sun*a, Qidong Youa
a Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing 210009, P. R. of China
Fax: +86(25)83271351; e-Mail: chslp@cpu.edu.cn;
b School of Chemistry and Chemical Engineering, Sun Yat-sen University, Guangzhou 510275, P. R. of China
Further Information

Publication History

Received 21 November 2008
Publication Date:
20 March 2009 (online)

    Permissions and Reprints All articles of this category

Abstract

Starting from commercially available halonitropyridines and haloaminopyridines, 2-substituted-oxazolo[5,4-b]pyridines, and 2-aryl-oxazolo[4,5-b]pyridines were synthesized in good yields by using a Cu(I)-mediated cyclization of halopyridylamides as a key step.

Key words

copper-catalyzed cyclization - synthesis - heterocycles - oxazolo[5,4-b]pyridines - oxazolo[4,5-b]pyridines

    References and Notes

  • 1a Rodriguez AD. Ramirez C. Rodriguez II. Gonzales E. Org. Lett.  1999,  1:  527 
    Google Scholar
  • 1b Kobayashi J. Madono T. Shigemori H. Tetrahedron Lett.  1995,  36:  5589 
    Google Scholar
  • 1c Sun LQ. Chen J. Bruce M. Deskus JA. Epperson JR. Takaki K. Johnson G. Iben L. Mahle CD. Ryan E. Xu C. Bioorg. Med. Chem. Lett.  2004,  14:  3799 
    Google Scholar
  • 1d Paramshivappa R. Kumar PP. Subba Rao PV. Srinivase Rao A. Bioorg. Med. Chem. Lett.  2003,  13:  657 
    Google Scholar
  • 1e Kumar D. Jacob MR. Reynolds MB. Kerwin SM. Bioorg. Med. Chem.  2002,  10:  3997 
    Google Scholar
  • 1f Lopez-Tudanca PL. Labeaga L. Innerarity A. Alonso-Cires L. Tapia I. Mosquera R. Orjales A. Bioorg. Med. Chem.  2003,  11:  2709 
    Google Scholar
  • 2a Yildiz-Oren I. Yalcin I. Aki-Sener E. Ucarturk N. Eur. J. Med. Chem.  2004,  39:  291 
    Google Scholar
  • 2b Tekiner-Gulbas B. Temiz-Arpaci O. Yildiz I. Aki-Sener E. Yalcin I. SAR QSAR Environ Res.  2006,  17:  121 
    Google Scholar
  • 2c Clark RL. Pessolano AA. Witzel B. Lanza T. Shen TY. J. Med. Chem.  1978,  21:  1158 
    Google Scholar
  • 2d Boger DL. Miyauchi H. Du W. Hardouin C. Fecik RA. Cheng H. Hwang I. Hedrick MP. Leung D. Acevedo O. Guimarães CRW. Jorgensen WL. Cravatt BF. J. Med. Chem.  2005,  48:  1849 
    Google Scholar
  • 2e Deng JZ. McMasters DR. Rabbat PMA. Williams PD. Coburn CA. Yan YW. Kuo LC. Lewis SD. Lucas BJ. Krueger JA. Strulovici B. Vacca JP. Lylea TA. Burgeya CS. Bioorg. Med. Chem. Lett.  2005,  15:  4411 
    Google Scholar
  • 2f Walczynński K. Zuiderveld OP. Timmerman H. Eur. J. Med. Chem.  2005,  15 
    Google Scholar
  • 3a Doise M. Dennin F. Blondeau D. Sliwa H. Tetrahedron Lett.  1990,  31:  1155 
    Google Scholar
  • 3b Doise M. Blondeau D. Sliwa H. Synth. Commun.  1992,  22:  2891 
    Google Scholar
  • 3c Myllymäki MJ. Koskinen AMP. Tetrahedron Lett.  2007,  48:  2295 
    Google Scholar
  • 3d Heuser S. Keenanb M. Weichert AG. Tetrahedron Lett.  2005,  46:  9001 
    Google Scholar
  • 3e Phoon CW. Ng PY. Ting AE. Yeob SL. Sima MM. Bioorg. Med. Chem. Lett.  2001,  11:  1647 
    Google Scholar
  • 4a Flouzat C. Guillaumet G. Synthesis  1990,  64 
    Google Scholar
  • 4b Walczynński K. Zuiderveld OP. Timmerman H. Eur. J. Med. Chem.  2005,  40:  15 
    Google Scholar
  • 4c Garnier E. Blanchard S. Rodriguez I. Jarry C. Léger J.-M. Caubère P. Guillaumet G. Synthesis  2003,  2033 
    Google Scholar
  • 5 Altenhoff G. Glorius F. Adv. Synth. Catal.  2004,  346:  1661 
    CrossrefGoogle Scholar
  • 6a Ley SV. Thomas AW. Angew. Chem. Int. Ed.  2003,  42:  5400 
    Google Scholar
  • 6b Kunz K. Scholz U. Ganzer D. Synlett  2003,  2428 
    Google Scholar
  • 6c Finet JP. Fedorov AY. Combes S. Boyer G. Curr. Org. Chem.  2002,  6:  597 
    Google Scholar
  • 7 Evindar G. Batey RA. J. Org. Chem.  2006,  71:  1802 
    CrossrefGoogle Scholar
8

Typical Procedure for the Synthesis and Purification of 3a
To a mixture of 2a (2.0 mmol), CuI (0.1 mmol), N,N′-dimethylethylenediamine (0.2 mmol), and K2CO3 (4.0 mmol) was added dry toluene (5.0 mL) under a nitrogen atmosphere. The reaction was refluxed for 12 h and then allowed to cool to r.t. The crude mixture was added to 10 mL H2O and then was extracted by CH2Cl2 (2 × 20 mL). The organic layer was dried over anhyd Na2SO4 and concentrated in vacuo to give the crude product, which was further purified by flash chromatography over silica gel column with PE-EtOAc (5:1) to give the pure product 3a.

9

Selected Spectral Data
Compound 3a: mp 101-102 ˚C. R f  = 0.55 (EtOAc-PE, 1:2). IR (KBr): 2913, 1617, 1544 cm-¹. ¹H NMR (300 MHz, CDCl3): δ = 8.38 (dd, J = 5.1, 1.5 Hz, 1 H), 8.34 (d, J = 1.5 Hz, 1 H), 8.34 (d, J = 2.1 Hz, 1 H), 8.10 (dd, J = 7.8, 1.5 Hz, 1 H), 7.55-7.62 (m, 3 H), 7.36-7.41 (m, 1 H). MS (EI):
m/z = 196 [M]+. Anal. Calcd for C12H8N2O: C, 73.46; H, 4.11; N, 14.28. Found: C, 73.46; H, 4.43; N, 14.18.
Compound 3i: mp 79-81 ˚C. R f  = 0.38 (EtOAc-PE, 1:2). IR (KBr): 2924, 1602, 1523 cm-¹. ¹H NMR (300 MHz, CDCl3): δ = 8.35 (dd, J = 4.2, 1.5 Hz, 1 H), 8.21 (dd, J = 7.8, 1.5 Hz, 1 H), 8.12 (dd, J = 7.8, 1.5 Hz, 1 H), 7.53-7.56 (m, 1 H), 7.32-7.37 (m, 1 H), 7.10-7.16 (m, 2 H), 4.05 (s, 3 H). MS (EI): m/z = 226 [M]+. Anal. Calcd for C13H10N2O2: C, 69.02; H, 4.46; N, 12.38. Found: C, 68.67; H, 4.34; N, 12.38.
Compound 3k: mp 172-174 ˚C. R f  = 0.42 (EtOAc-PE, 1:2). IR (KBr): 1496, 1620, 1223 cm-¹. ¹H NMR (300 MHz, CDCl3): δ = 8.34 (dd, J = 4.5, 1.5 Hz, 1 H), 8.05 (dd, J = 7.8, 1.5 Hz, 1 H), 7.54 (s, 2 H), 7.33-7.37 (m, 1 H), 4.04 (s, 9 H). MS (EI): m/z = 286 [M]+. Anal. Calcd for C15H14N2O4: C, 62.93; H, 4.93; N, 9.79; Found: C, 63.12; H, 4.74; N, 9.78.
Compound 6a: mp 163-164 ˚C. R f  = 0.38 (EtOAc-PE, 1:2). IR (KBr): 2920, 1670, 1580 cm-¹. ¹H NMR (300 MHz, CDCl3): δ = 8.56 (s, 1 H), 8.46 (dd, J = 1.5, 7.2 Hz, 2 H), 7.81 (s, 1 H), 7.75-7.65 (m, 3 H), 2.65 (s, 3 H). ¹³C NMR (75 MHz, CDCl3): δ = 165.1, 154.4, 147.3, 132.3, 130.6, 129.0, 128.0, 126.7, 118.5, 18.9. ESI-MS: m/z = 211 [M+ + 1]. Anal. Calcd for C13H10N2O: C, 74.27; H, 4.79; N, 13.33. Found: C, 74.05; H, 4.77; N, 13.28.
Compound 6b: mp 165-167 ˚C. R f  = 0.35 (EtOAc-PE, 1:2). IR (KBr): 2918, 1620, 1550 cm-¹.¹H NMR (300 MHz, CDCl3): δ = 8.57 (s, 1 H), 8.32 (d, J = 8.4 Hz, 2 H), 8.01 (d, J = 8.3 Hz, 2 H), 7.84 (s, 1 H), 3.95 (s, 1 H), 2.64 (s, 3 H). ESI-MS: m/z = 241 [M+ + 1]. Anal. Calcd for C13H10N2O: C, 69.99; H, 5.03; N, 11.66. Found: C, 69.78; H, 4.98; N, 11.69.
Compound 6c: mp 193-194 ˚C. R f  = 0.32 (EtOAc-PE, 1:2). IR (KBr): 2918, 1610, 1560 cm-¹.¹H NMR (300 MHz, CDCl3): δ = 8.59 (s, 1 H), 8.16 (d, J = 8.7 Hz, 2 H), 8.04 (d, J = 8.1 Hz, 2 H), 7.84 (s, 1 H), 2.64 (s, 3 H). ¹³C NMR (75 Hz, CDCl3): δ = 164.3, 154.2, 147.7, 143.3, 138.4, 130.9, 129.3, 126.2, 118.6, 99.5, 18.9. ESI-MS: m/z = 337 [M+ + 1]. Anal. Calcd for C13H9IN2O: C, 46.45; H, 2.70, N, 8.33. Found: C, 46.53; H, 2.75; N, 8.40.